Systematically Prioritizing Candidates in Genome-Based Drug Repurposing-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Systematically Prioritizing Candidates in Genome-Based Drug Repurposing

Published:2019-12-01 Issue:8 Volume:17 Page:352-363
ISSN:1540-658X
Container-title:ASSAY and Drug Development Technologies
language:en
Short-container-title:ASSAY and Drug Development Technologies

Author:

Challa Anup P.¹,Lavieri Robert R.¹,Lewis Judith T.¹,Zaleski Nicole M.¹,Shirey-Rice Jana K.¹,Harris Paul A.²,Aronoff David M.³⁴,Pulley Jill M.¹

Affiliation:

1. Vanderbilt Institute for Clinical and Translational Research, Vanderbilt University Medical Center, Nashville, Tennessee.

2. Department of Biomedical Informatics, Vanderbilt University Medical Center, Nashville, Tennessee.

3. Division of Infectious Diseases, Department of Medicine, Vanderbilt University School of Medicine, Nashville, Tennessee.

4. Department of Pathology, Microbiology and Immunology, Vanderbilt University School of Medicine, Nashville, Tennessee.

Publisher

Mary Ann Liebert Inc

Subject

Drug Discovery,Molecular Medicine

Link

https://www.liebertpub.com/doi/pdf/10.1089/adt.2019.950

Reference22 articles.

1. The Drug Repurposing Hub: a next-generation drug library and information resource

2. Can you teach old drugs new tricks?

3. Diagnosing the decline in pharmaceutical R&D efficiency

4. Lessons learned from the fate of AstraZeneca's drug pipeline: a five-dimensional framework

Cited by 12 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The landscape of the methodology in drug repurposing using human genomic data: a systematic review;Briefings in Bioinformatics;2024-01-22

2. Repurposing N-acetylcysteine for management of non-acetaminophen induced acute liver failure: an evidence scan from a global health perspective;Translational Gastroenterology and Hepatology;2024-01

3. An update on the global treatment of invasive fungal infections;Future Microbiology;2023-11

4. Polyvalent human immunoglobulin for infectious diseases: Potential to circumvent antimicrobial resistance;Frontiers in Immunology;2023-01-09

5. The grand challenge of discovering new cardiovascular drugs;Frontiers in Drug Discovery;2022-09-23

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3